Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.

Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P.

Am Heart J. 2006 Jul;152(1):27-38. Review.

PMID:
16824829
2.
3.

The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.

Ma J, Yang W, Fang N, Zhu W, Wei M.

Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):596-603. doi: 10.1016/j.numecd.2009.07.004. Epub 2009 Oct 9.

PMID:
19819121
4.

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Control Group, Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M.

Diabetologia. 2009 Nov;52(11):2288-98. doi: 10.1007/s00125-009-1470-0. Epub 2009 Aug 5. Erratum in: Diabetologia. 2009 Nov;52(1):2470. Control Group [added].

PMID:
19655124
5.
6.

Diabetes and peripheral vascular disease.

Huysman E, Mathieu C.

Acta Chir Belg. 2009 Oct;109(5):587-94. Review.

PMID:
19994800
7.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

8.

The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.

Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T.

J Diabetes Complications. 2009 Mar-Apr;23(2):89-94. doi: 10.1016/j.jdiacomp.2008.01.006. Epub 2008 Mar 20.

PMID:
18358749
9.

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.

PMID:
14583175
10.

Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.

Kinsley B.

Clin Ther. 2007;29 Suppl D:S153-60. doi: 10.1016/j.clinthera.2007.12.015. Review.

PMID:
18191067
11.

Glucose lowering and cardiovascular disease: what do we know and what should we do?

Cheng AY, Leiter LA.

Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S25-31. doi: 10.1097/01.hjr.0000368194.32356.5f. Review.

PMID:
20489417
12.

[Glycemic control and cardiovascular benefit: What do we know today?].

Hanefeld M, Schönauer M, Forst T.

Dtsch Med Wochenschr. 2010 Feb;135(7):301-7. doi: 10.1055/s-0029-1244853. Epub 2010 Feb 9. Review. German.

PMID:
20146161
13.
14.

Diabetes and cardiovascular disease: the role of glycemic control.

Cheng AY, Leiter LA.

Curr Diab Rep. 2009 Feb;9(1):65-72.

PMID:
19192427
15.

Care of adults with type 2 diabetes mellitus. A review of the evidence.

O'Connor PJ, Spann SJ, Woolf SH.

J Fam Pract. 1998 Nov;47(5 Suppl):S13-22. Review.

PMID:
9834750
17.

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.

Shogbon AO, Levy SB.

Am J Health Syst Pharm. 2010 May 15;67(10):798-805. doi: 10.2146/ajhp090211. Review.

PMID:
20479101
18.

Blood rheology in patients with diabetes mellitus.

Le Dévéhat C, Vimeux M, Khodabandehlou T.

Clin Hemorheol Microcirc. 2004;30(3-4):297-300.

PMID:
15258357
19.
20.

Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.

Weiss IA, Valiquette G, Schwarcz MD.

Cardiol Rev. 2009 Jul-Aug;17(4):165-75. doi: 10.1097/CRD.0b013e3181a7b34c. Review.

PMID:
19525678

Supplemental Content

Support Center